Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Coll Cardiol. 2010 Oct 12;56(16):1287-97. doi: 10.1016/j.jacc.2010.05.039.

Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.

Author information

1
Northwestern University, Chicago, IL, USA.

Abstract

Cytokine therapy promises to provide a noninvasive treatment option for ischemic heart disease. Cytokines are thought to influence angiogenesis directly via effects on endothelial cells or indirectly through progenitor cell-based mechanisms or by activating the expression of other angiogenic agents. Several cytokines mobilize progenitor cells from the bone marrow or are involved in the homing of mobilized cells to ischemic tissue. The recruited cells contribute to myocardial regeneration both as a structural component of the regenerating tissue and by secreting angiogenic or antiapoptotic factors, including cytokines. To date, randomized, controlled clinical trials have not reproduced the efficacy observed in pre-clinical and small-scale clinical investigations. Nevertheless, the list of promising cytokines continues to grow, and combinations of cytokines, with or without concurrent progenitor cell therapy, warrant further investigation.

PMID:
20888519
PMCID:
PMC3123891
DOI:
10.1016/j.jacc.2010.05.039
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center